{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:48Z","timestamp":1791685428817,"version":"4.3.4"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DST","award":["SR\/S2\/RJN-28\/2012"],"award-info":[{"award-number":["SR\/S2\/RJN-28\/2012"]}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F.30-114\/2015"],"award-info":[{"award-number":["F.30-114\/2015"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["23\/12\/2012"],"award-info":[{"award-number":["23\/12\/2012"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DST-SERB","award":["YSS\/2015\/001267"],"award-info":[{"award-number":["YSS\/2015\/001267"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.pharmthera.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T10:01:19Z","timestamp":1468144879000},"page":"106-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders"],"prefix":"10.1016","volume":"166","author":[{"given":"Shabir Ahmad","family":"Ganai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Banday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Altaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.07.001_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0010","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/hmg\/ddv099","article-title":"Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice","volume":"24","author":"Achour","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0015","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.158.3808.1600","article-title":"Actinomycin D blocks formation of memory of shock-avoidance in goldfish","volume":"158","author":"Agranoff","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/24190","article-title":"Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A","volume":"396","author":"Ait-Si-Ali","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration","volume":"42","author":"Alarcon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","article-title":"New nomenclature for chromatin-modifying enzymes","volume":"131","author":"Allis","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrfmmm.2006.09.009","article-title":"Histone modifications in response to DNA damage","volume":"618","author":"Altaf","year":"2007","journal-title":"Mutat Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1615\/CritRevEukaryotGeneExpr.v9.i1.20","article-title":"CREB-mediated transcriptional control","volume":"9","author":"Andrisani","year":"1999","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0050","first-page":"263","article-title":"Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools","volume":"41","author":"Anne-Laurence","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cne.21974","article-title":"Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain","volume":"513","author":"Azevedo","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0060","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0065","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0070","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"134","key":"10.1016\/j.pharmthera.2016.07.001_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2015.04.011","article-title":"Lacosamide reduces HDAC levels in the brain and improves memory: potential for treatment of Alzheimer's disease","volume":"134","author":"Bang","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1101\/lm.917508","article-title":"Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory","volume":"15","author":"Barrett","year":"2008","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0095","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1073\/pnas.1214266110","article-title":"Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1","volume":"110","author":"Bellet","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0100","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1172\/JCI79942","article-title":"HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models","volume":"125","author":"Benito","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature05915","article-title":"The complex language of chromatin regulation during transcription","volume":"447","author":"Berger","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2008.09.018","article-title":"The SIRT2 deacetylase regulates autoacetylation of p300","volume":"32","author":"Black","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1101\/lm.5.4.365","article-title":"Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA","volume":"5","author":"Bourtchouladze","year":"1998","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0120","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/npp.2010.117","article-title":"Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B\/H4 acetylation-dependent transcriptional events in the rat hippocampus","volume":"35","author":"Bousiges","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1471-4159.2003.01581.x","article-title":"Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis","volume":"84","author":"Boutillier","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0130","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1128\/MCB.00066-07","article-title":"Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos","volume":"27","author":"Bu","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0135","doi-asserted-by":"crossref","first-page":"22687","DOI":"10.1073\/pnas.1012851108","article-title":"CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease","volume":"107","author":"Caccamo","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0140","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hipo.20990","article-title":"HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons","volume":"22","author":"Calfa","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0150","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","article-title":"A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice","volume":"33","author":"Chatterjee","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0155","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.281.5382.1505","article-title":"CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV","volume":"281","author":"Chawla","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/MCB.21.2.476-487.2001","article-title":"Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators","volume":"21","author":"Chen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/hmg\/ddr474","article-title":"Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model","volume":"21","author":"Chen","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0170","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage","volume":"165","author":"Chen","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0180","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1093\/emboj\/cdf548","article-title":"Control of CBP co-activating activity by arginine methylation","volume":"21","author":"Chevillard-Briet","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0185","first-page":"488","article-title":"Neuropathology of amyotrophic lateral sclerosis: new perspectives on an old disease","volume":"96","author":"Chou","year":"1997","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0190","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0200","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s12272-015-0571-1","article-title":"Histone deacetylase inhibitors in hematological malignancies and solid tumors","volume":"38","author":"Chun","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation","volume":"30","author":"Cong","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0215","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1021\/bi9907274","article-title":"Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat","volume":"38","author":"Creaven","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003699","article-title":"Binding of TFIIIC to SINE elements controls the relocation of activity-dependent neuronal genes to transcription factories","volume":"9","author":"Crepaldi","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/cbic.200900721","article-title":"The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme","volume":"11","author":"Dal Piaz","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2009.06.028","article-title":"Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury","volume":"163","author":"Dash","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0235","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0960-9822(02)01387-8","article-title":"Crosstalk between CARM1 methylation and CBP acetylation on histone H3","volume":"12","author":"Daujat","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0240","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-2836(02)00386-8","article-title":"Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution","volume":"319","author":"Davey","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17482960802226148","article-title":"Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice","volume":"10","author":"Del Signore","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0968-0004(02)00005-1","article-title":"Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases","volume":"28","author":"Denu","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/acn3.147","article-title":"The promise and perils of HDAC inhibitors in neurodegeneration","volume":"2","author":"Didonna","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","article-title":"HDAC inhibitors and neurodegeneration: at the edge between protection and damage","volume":"62","author":"Dietz","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","article-title":"Prospects: histone deacetylase inhibitors","volume":"96","author":"Dokmanovic","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0270","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008964","article-title":"GCN5 is a positive regulator of origins of DNA replication in Saccharomyces cerevisiae","volume":"5","author":"Espinosa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrrev.2016.03.005","article-title":"The many faces of histone H3K79 methylation","volume":"768","author":"Farooq","year":"2016","journal-title":"Mutat Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: emerging patterns and implications","volume":"13","author":"Feil","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0290","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0295","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0300","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/embj.201387637","article-title":"Epigenetic memory: the Lamarckian brain","volume":"33","author":"Fischer","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuropharm.2014.01.038","article-title":"Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?","volume":"80","author":"Fischer","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0310","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","article-title":"Targeting the correct HDAC(s) to treat cognitive disorders","volume":"31","author":"Fischer","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0315","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature05772","article-title":"Recovery of learning and memory is associated with chromatin remodelling","volume":"447","author":"Fischer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0320","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0031-9384(73)90221-7","article-title":"The influence of duration of protein synthesis inhibition on memory","volume":"10","author":"Flood","year":"1973","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0325","first-page":"1","article-title":"Histone deacetylase inhibitor pracinostat in doublet therapy: a unique strategy to improve therapeutic efficacy and to tackle herculean cancer chemoresistance","author":"Ganai","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1568026615666150813145800","article-title":"Panobinostat: the small molecule metalloenzyme inhibitor with marvelous anticancer activity","volume":"16","author":"Ganai","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570159X13666151021111609","article-title":"Histone deacetylase (HDAC) inhibitors \u2014 emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration","volume":"14","author":"Ganai","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/07391102.2013.879073","article-title":"Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of class II HDAC isoforms","volume":"33","author":"Ganai","year":"2015","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0345","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/NMM:5:3:235","article-title":"Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity","volume":"5","author":"Gardian","year":"2004","journal-title":"Neruomol Med"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0355","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/brain\/awr142","article-title":"The histone acetyltransferase p300 promotes intrinsic axonal regeneration","volume":"134","author":"Gaub","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0360","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/hmg\/ddr108","article-title":"Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model","volume":"20","author":"Gehrking","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0370","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"Gregoire","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0375","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1126\/science.1080386","article-title":"Polyubiquitination of p53 by a ubiquitin ligase activity of p300","volume":"300","author":"Grossman","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0380","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0092-8674(02)01074-7","article-title":"Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure","volume":"111","author":"Guan","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80553-X","article-title":"Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A","volume":"96","author":"Hamamori","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0395","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0896-6273(00)80737-0","article-title":"Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and l-type calcium channels","volume":"22","author":"Hardingham","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0400","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1111\/bph.13208","article-title":"Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors","volume":"172","author":"Harrison","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0405","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuron.2014.01.028","article-title":"SIRT1 in neurodevelopment and brain senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0410","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0415","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0420","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1471-4159.2003.01991.x","article-title":"Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein","volume":"87","author":"Hoshino","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0425","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1073\/pnas.0407643101","article-title":"Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells","volume":"101","author":"Hsieh","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau\u2014a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0435","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.M508786200","article-title":"HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin","volume":"280","author":"Iwata","year":"2005","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2016.07.001_bb0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0445","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/NEN.0b013e3181ddd404","article-title":"Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis","volume":"69","author":"Janssen","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0450","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation","volume":"137","author":"Jeong","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0455","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1073\/pnas.1415195112","article-title":"HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation","volume":"112","author":"Jia","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddg002","article-title":"Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein","volume":"12","author":"Jiang","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0465","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0470","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1523\/JNEUROSCI.3739-12.2013","article-title":"Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model","volume":"33","author":"Johnson","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0475","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/hmg\/ddg039","article-title":"Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein\u2013Taybi syndrome","volume":"12","author":"Kalkhoven","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0480","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1038\/srep06076","article-title":"Camello, a novel family of histone acetyltransferases that acetylate histone H4 and is essential for zebrafish development","volume":"4","author":"Karmodiya","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/35012097","article-title":"ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation","volume":"405","author":"Kawasaki","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0490","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1523\/JNEUROSCI.2089-12.2012","article-title":"An essential role for histone deacetylase 4 in synaptic plasticity and memory formation","volume":"32","author":"Kim","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0495","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","article-title":"Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity","volume":"60","author":"Kim","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0500","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0505","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.184.4139.868","article-title":"Chromatin structure: a repeating unit of histones and DNA","volume":"184","author":"Kornberg","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0510","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1074\/jbc.C110.194233","article-title":"Histone deacetylases 9 and 10 are required for homologous recombination","volume":"286","author":"Kotian","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0515","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0520","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1101\/gad.14.3.272","article-title":"Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP","volume":"14","author":"Kung","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1097-2765(00)80452-9","article-title":"HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF","volume":"5","author":"Lau","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0530","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fncel.2013.00243","article-title":"Histone deacetylases and their role in motor neuron degeneration","volume":"7","author":"Lazo-G\u00f3mez","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0535","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neuron.2009.04.025","article-title":"Retinoid signaling and neurogenin2 function are coupled for the specification of spinal motor neurons through a chromatin modifier CBP","volume":"62","author":"Lee","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0540","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.embor.embor941","article-title":"Regulating histone acetyltransferases and deacetylases","volume":"4","author":"Legube","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0545","doi-asserted-by":"crossref","first-page":"40545","DOI":"10.1074\/jbc.M402229200","article-title":"Regulation of histone acetylation during memory formation in the hippocampus","volume":"279","author":"Levenson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0550","doi-asserted-by":"crossref","first-page":"45004","DOI":"10.1074\/jbc.M205259200","article-title":"Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0555","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/emboj\/cdg028","article-title":"MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300","volume":"22","author":"Li","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0560","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-169X.2008.01041.x","article-title":"Proper Gcn5 histone acetyltransferase expression is required for normal anteroposterior patterning of the mouse skeleton","volume":"50","author":"Lin","year":"2008","journal-title":"Develop Growth Differ"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0565","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncb1545","article-title":"Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2","volume":"9","author":"Linares","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0570","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tins.2010.01.007","article-title":"Epigenetic regulation of oligodendrocyte identity","volume":"33","author":"Liu","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0575","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1126\/science.271.5251.978","article-title":"Chain migration of neuronal precursors","volume":"271","author":"Lois","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0580","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tig.2014.09.003","article-title":"Can changes in histone acetylation contribute to memory formation?","volume":"30","author":"Lopez-Atalaya","year":"2014","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0585","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/emboj.2011.299","article-title":"CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement","volume":"30","author":"Lopez-Atalaya","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0590","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jmedgenet-2011-100354","article-title":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome","volume":"49","author":"Lopez-Atalaya","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0595","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1093\/nar\/gkt590","article-title":"Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition","volume":"41","author":"Lopez-Atalaya","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0600","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8A resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0605","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.celrep.2012.07.006","article-title":"Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns","volume":"2","author":"Lundby","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054463","article-title":"A naturally-occurring histone acetyltransferase inhibitor derived from Garcinia indica impairs newly acquired and reactivated fear memories","volume":"8","author":"Maddox","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0615","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/dneu.20637","article-title":"HDAC4 inhibits cell-cycle progression and protects neurons from cell death","volume":"68","author":"Majdzadeh","year":"2008","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0620","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trci.2015.08.001","article-title":"Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein\/presenilin 1 (APP\/PS1) mice","volume":"1","author":"Majid","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0625","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1021\/jp067655s","article-title":"Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy","volume":"111","author":"Mantelingu","year":"2007","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0630","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1523\/JNEUROSCI.0133-11.2011","article-title":"Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300","volume":"31","author":"Marek","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039456","article-title":"N-Myc and GCN5 regulate significantly overlapping transcriptional programs in neural stem cells","volume":"7","author":"Martinez-Cerdeno","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0640","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0645","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/bj3530013","article-title":"Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter","volume":"353","author":"Mehra-Chaudhary","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0655","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1523\/JNEUROSCI.2247-06.2006","article-title":"The transcriptional coactivator Querkopf controls adult neurogenesis","volume":"26","author":"Merson","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0660","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1523\/JNEUROSCI.0027-10.2010","article-title":"SIRT1 is essential for normal cognitive function and synaptic plasticity","volume":"30","author":"Michan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0665","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nsmb.1899","article-title":"Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining","volume":"17","author":"Miller","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0670","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/MCB.26.9.3550-3564.2006","article-title":"Neuroprotection by histone deacetylase-related protein","volume":"26","author":"Morrison","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0675","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0680","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1126\/science.284.5413.479","article-title":"Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300","volume":"284","author":"Nakashima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0685","first-page":"4351","volume":"Vol. 36","author":"Neidl","year":"2016"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0690","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.8066450","article-title":"Requirement of a critical period of transcription for induction of a late phase of LTP","volume":"265","author":"Nguyen","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmed.2009.11.002","article-title":"Elongator \u2014 an emerging role in neurological disorders","volume":"16","author":"Nguyen","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0700","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/8.3.387","article-title":"Truncated CBP protein leads to classical Rubinstein\u2013Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism","volume":"8","author":"Oike","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0705","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp.59.3.266","article-title":"Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles","volume":"59","author":"Orrell","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0710","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0715","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0720","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1523\/JNEUROSCI.4507-10.2011","article-title":"Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions","volume":"31","author":"Pedre","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0725","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/npp.2012.86","article-title":"The role of histone acetylation in memory formation and cognitive impairments","volume":"38","author":"Peixoto","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0730","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1186088","article-title":"Altered histone acetylation is associated with age-dependent memory impairment in mice","volume":"328","author":"Peleg","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0735","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/stem.1606","article-title":"MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells","volume":"32","author":"Perez-Campo","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004090","article-title":"Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity","volume":"3","author":"Pfister","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0750","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2325-9787.1000e102","article-title":"Modulating epigenetic HAT activity : a promising therapeutic option for neurological disease ?","volume":"1","author":"Pirooznia","year":"2012","journal-title":"J Mol Cloning Genet Recombination"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0760","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fncel.2013.00030","article-title":"Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities","volume":"7","author":"Pirooznia","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0765","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1534\/genetics.112.144667","article-title":"Epigenetic regulation of axonal growth of Drosophila pacemaker cells by histone acetyltransferase tip60 controls sleep","volume":"192","author":"Pirooznia","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041776","article-title":"Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model","volume":"7","author":"Pirooznia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0775","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cell.2005.06.026","article-title":"Genome-wide map of nucleosome acetylation and methylation in yeast","volume":"122","author":"Pokholok","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0780","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/MCB.22.23.8353-8365.2002","article-title":"Histone H3 and the histone acetyltransferase Hat1p contribute to DNA double-strand break repair","volume":"22","author":"Qin","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0785","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0790","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuron.2007.09.032","article-title":"Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli","volume":"56","author":"Renthal","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0795","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1083\/jcb.106.4.1017","article-title":"Micronuclei and the cytoplasm of growing Tetrahymena contain a histone acetylase activity which is highly specific for free histone H4","volume":"106","author":"Richman","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0800","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0805","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1523\/JNEUROSCI.22-07-02679.2002","article-title":"Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory","volume":"22","author":"Rochefort","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0810","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","article-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration","volume":"22","author":"Rouaux","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0815","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Rouaux","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0820","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0825","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0830","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026202","article-title":"dTip60 HAT activity controls synaptic bouton expansion at the Drosophila neuromuscular junction","volume":"6","author":"Sarthi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0840","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bcp.2004.11.008","article-title":"Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor","volume":"69","author":"Sasakawa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0845","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.bmcl.2008.04.017","article-title":"Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases","volume":"18","author":"Sbardella","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0850","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s13311-013-0204-7","article-title":"Acetyltransferases (HATs) as targets for neurological therapeutics","volume":"10","author":"Schneider","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0855","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0960-9822(01)00020-3","article-title":"Enok encodes a Drosophila putative histone acetyltransferase required for mushroom body neuroblast proliferation","volume":"11","author":"Scott","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0860","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0865","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1021\/nl801503m","article-title":"Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: delivery of membrane-impermeable molecule to modulate gene expression in vivo","volume":"8","author":"Selvi","year":"2008","journal-title":"Nano Lett"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0870","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ncb1747","article-title":"Nitric oxide-induced nuclear GAPDH activates p300\/CBP and mediates apoptosis","volume":"10","author":"Sen","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0875","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00441-014-1835-7","article-title":"Crafting the brain \u2014 role of histone acetyltransferases in neural development and disease","volume":"356","author":"Sheikh","year":"2014","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0880","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1128\/MCB.21.21.7509-7522.2001","article-title":"The HOX homeodomain proteins block CBP histone acetyltransferase activity","volume":"21","author":"Shen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0885","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-4159.2010.06892.x","article-title":"The histone acetyltransferase Elp3 plays in active role in the control of synaptic bouton expansion and sleep in Drosophila","volume":"115","author":"Singh","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0890","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-011-0751-3","article-title":"Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression","volume":"352","author":"Soliman","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0895","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/mol.109.062174","article-title":"Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration","volume":"77","author":"Song","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0900","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/emboj\/20.8.1984","article-title":"Transcription factor-dependent regulation of CBP and P\/CAF histone acetyltransferase activity","volume":"20","author":"Soutoglou","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0905","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1523\/JNEUROSCI.04-12-03080.1984","article-title":"Blockade of long-term potentiation in rat hippocampal CA1 region by inhibitors of protein synthesis","volume":"4","author":"Stanton","year":"1984","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0910","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0915","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/MMBR.64.2.435-459.2000","article-title":"Acetylation of histones and transcription-related factors","volume":"64","author":"Sterner","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0920","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","article-title":"The basics of brain development","volume":"20","author":"Stiles","year":"2010","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0925","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0930","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0935","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(01)00224-0","article-title":"Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms","volume":"104","author":"Sun","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0940","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4773(00)00360-9","article-title":"Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein","volume":"95","author":"Tanaka","year":"2000","journal-title":"Mech Dev"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0945","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0950","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0955","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.127.12.2537","article-title":"Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development","volume":"127","author":"Thomas","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0960","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nsmb740","article-title":"Regulation of the p300 HAT domain via a novel activation loop","volume":"11","author":"Thompson","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0965","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"Valor","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0970","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1523\/JNEUROSCI.4737-10.2011","article-title":"Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability","volume":"31","author":"Valor","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0975","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.2174\/13816128113199990382","article-title":"Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders","volume":"19","author":"Valor","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0980","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","article-title":"Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation","volume":"27","author":"Vecsey","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0985","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1093\/hmg\/ddu081","article-title":"The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1","volume":"23","author":"Venkatraman","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0990","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4161\/epi.5.2.10942","article-title":"Tuning acetylated chromatin with HAT inhibitors: a novel tool for therapy","volume":"5","author":"Vernarecci","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb0995","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1000","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nbd.2009.10.001","article-title":"Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein\u2013Taybi syndrome etiology","volume":"37","author":"Viosca","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1005","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1074\/jbc.M109.087585","article-title":"SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.10.037","article-title":"HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells","volume":"467","author":"Wang","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.devcel.2009.10.023","article-title":"CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein\u2013Taybi syndrome brain","volume":"18","author":"Wang","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1020","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1523\/JNEUROSCI.0178-12.2012","article-title":"p300\/CBP-associated factor selectively regulates the extinction of conditioned fear","volume":"32","author":"Wei","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1101\/lm.86605","article-title":"Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage","volume":"12","author":"Wood","year":"2005","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1035","first-page":"14","article-title":"Valproic acid neuroprotection in the 6-OHDA model of Parkinsons disease is possibly related to its anti-inflammatory and HDAC inhibitory properties","volume":"2015","author":"Ximenes","year":"2015","journal-title":"J Neurodegener Dis"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/79973","article-title":"Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development","volume":"26","author":"Xu","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1045","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1073\/pnas.97.21.11303","article-title":"Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B\/GCN5 in mouse embryogenesis","volume":"97","author":"Yamauchi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0092-8674(00)81165-4","article-title":"Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300","volume":"93","author":"Yao","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.07.001_bb1055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(01)03309-9","article-title":"Bromodomain: an acetyl-lysine binding domain","volume":"513","author":"Zeng","year":"2002","journal-title":"FEBS Lett"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T18:44:45Z","timestamp":1656787485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816301103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":211,"alternative-id":["S0163725816301103"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}